Eidos Therapeutics Inc (EIDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | EIDX | CRSP | PCVX | ||
| Company | Eidos Therapeutics Inc | Crispr Therapeutics Ag | Vaxcyte Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 127.57 | 58.88 | 35.62 | ||
| High | 128.49 | 59.48 | 36.14 | ||
| Low | 116.83 | 55.88 | 35.17 | ||
| Last | 122.21 | 56.80 | 35.93 | ||
| Change | -6.23 | -2.20 | -0.31 | ||
| % Change | -4.85% | -3.73% | -0.86% | ||
| Volume | 335,500 | 2,890,400 | 1,947,300 | ||
| 20-Day Average Volume | 113,985 | 3,764,805 | 1,545,855 | ||
| Previous Close | 128.44 | 59.00 | 36.24 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 124.59 | 48.66 | 33.73 | ||
| 20-Day Raw Stochastic | 36.63% | 76.57% | 81.18% | ||
| 20-Day Relative Strength | 56.42% | 70.75% | 53.08% | ||
| Weighted Alpha | +136.62 | +11.76 | -34.90 | ||
| Today's Opinion | 88% Buy | 72% Buy | 40% Sell | ||
| Previous Opinion | 100% Buy | 56% Buy | 40% Sell | ||
| Last Month's Opinion | 100% Buy | 8% Sell | 40% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -3.40% since 01/15/21 | +8.87% since 07/03/25 | +8.06% since 07/03/25 | ||
| Low | 116.83 on 01/25/21 | 50.26 on 07/07/25 | 31.79 on 07/07/25 | ||
| High | 131.08 on 01/20/21 | 62.00 on 07/10/25 | 36.89 on 07/10/25 | ||
| 1-Month | |||||
| %Chg | -4.30% since 12/24/20 | +36.80% since 06/11/25 | +1.38% since 06/11/25 | ||
| Low | 116.24 on 01/05/21 | 39.81 on 06/12/25 | 31.79 on 07/07/25 | ||
| High | 132.54 on 01/04/21 | 62.00 on 07/10/25 | 36.89 on 07/10/25 | ||
| 3-Month | |||||
| %Chg | +66.75% since 10/23/20 | +44.53% since 04/11/25 | +15.16% since 04/11/25 | ||
| Low | 69.38 on 10/30/20 | 33.03 on 05/06/25 | 28.09 on 05/07/25 | ||
| High | 132.54 on 01/04/21 | 62.00 on 07/10/25 | 38.39 on 06/09/25 | ||
| 6-Month | |||||
| %Chg | +178.07% since 07/24/20 | +43.11% since 01/10/25 | -55.69% since 01/10/25 | ||
| Low | 38.44 on 07/31/20 | 30.04 on 04/07/25 | 27.66 on 04/10/25 | ||
| High | 132.54 on 01/04/21 | 62.00 on 07/10/25 | 93.77 on 01/28/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 4,750,670 | 4,905,475 | 4,635,113 | ||
| Shares Outstanding, K | 38,873 | 86,364 | 129,004 | ||
| Annual Sales | 26,690,000 | 37,310,000 | 0 | ||
| Annual Net Income | -37,840,000 | -366,250,000 | -463,930,000 | ||
| Last Quarter Sales | 130,000 | 870,000 | 0 | ||
| Last Quarter Net Income | -30,180,000 | -136,000,000 | -140,720,000 | ||
| 60-Month Beta | -0.16 | 1.82 | 1.19 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | -1.58 on 05/06/25 | -1.04 on 05/07/25 | ||
| Latest Earnings Date | 02/24/21 | 08/04/25 | 08/05/25 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||